CADTH | Evidence Driven
CADTH | Evidence Driven

Subcutaneous Immunoglobulin Therapy for Primary and Secondary Immune Deficiency Diseases

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Reference List
Project Number:
RA1194-000

Question

  1. What is the clinical effectiveness of subcutaneous immunoglobulin therapy in patients with primary or secondary immune deficiency diseases?

Key Message

No evidence was identified regarding the clinical effectiveness of subcutaneous immunoglobulin therapy in patients with primary or secondary immune deficiency diseases.

Files

Subcutaneous Immunoglobulin Therapy for Primary and Secondary Immune Deficiency… View PDF
Last Updated : October 20, 2021